Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Cutaneous × CTLA-4 Antigen × 90 days × Clear all

Sponsor

Conditions

Melanoma 9 Carcinoma, Renal Cell 6 Neoplasm Metastasis 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Penile Neoplasms 2 Myelodysplastic Syndromes 2 Meningioma 2 Carcinoma, Transitional Cell 2 Carcinoma, Endometrioid 2 Carcinoma, Basal Cell 2 Vulvar Neoplasms 1 Urachal adenocarcinoma 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Somatostatinoma 1 Small Cell Lung Carcinoma 1 Seminoma 1 Sarcoma, Kaposi 1 Rare Diseases 1 Pseudomyxoma Peritonei 1 Prostatic Neoplasms, Castration-Resistant 1 Pheochromocytoma 1

Interventions

Biopsy 4 fludarabine 3 Cyclophosphamide 3 romidepsin 2 pembrolizumab 2 mogamulizumab 2 Specimen Handling 2 tazemetostat 1 talimogene laherparepvec 1 ruxolitinib 1 hypericin 1 fludarabine phosphate 1 cc-486 1 belinostat 1 Valganciclovir 1 Urine Specimen Collection 1 Therapeutics 1 TNTCFP protein 1 Spinal Puncture 1 Polymerase Chain Reaction 1 Pharmacogenomic Variants 1 Nivolumab 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 MEDI-570 1 Light 1 Lenalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡